CIDP (chronic inflammatory demyelinating polyneuropathy): open trials in Greece

• NCT05327114

  Efficacy and Safety Study of Nipocalimab for Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

  Trial Treatment · Phase 2/3 · Janssen Research & Development, LLC

  University General Hospital Attikon, Athens · General Hospital Of Thessaloniki Papageorgiou, Efkarpia · University General Hospital of Thessaloniki - AHEPA, Thessaloniki

  Registry updated 2026-11-03

• NCT06920004

  A Study to Assess Efficacy and Safety of Empasiprubart Versus IVIg in Adults With CIDP

  Trial Treatment · Phase 3 · argenx

  University General Hospital of Alexandroupoli, Alexandroupoli · University General Hospital Attikon General Hospital Of West Attica H Agia Varvara, Athens

  Registry updated 2026-11-03

• NCT07091630

  A Study to Assess the Efficacy and Safety of Empasiprubart in Adults With CIDP

  Trial Treatment · Phase 3 · argenx

  University General Hospital of Alexandroupoli, Alexandroupoli · Eginitio Hospital, Athens

  Registry updated 2026-10-27

• NCT06290141

  A Study to Test the Efficacy and Safety of Riliprubart Against the Usual Treatment of Intravenous Immunoglobulin (IVIg) in People With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

  Trial Treatment · Phase 3 · Sanofi

  University General Hospital "ATTIKON" - General Hospital of West Attica "H AGIA VARVARA", Chaïdári · University General Hospital of Thessaloniki - AHEPA, Thessaloniki

  Registry updated 2026-10-19

• NCT07032662

  Imeroprubart in Adult Participants With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

  Trial Treatment · Phase 2 · Immunovant Sciences GmbH

  University General Hospital of Alexandroupoli, Alexandroupoli · Eginitio Hospital, Athens · University General Hospital "ATTIKON" - General Hospital of West Attica "H AGIA VARVARA", Chaïdári · General University Hospital of Larissa, Larissa · General University Hospital Of Patras, Patras

  Registry updated 2026-09-30

All CIDP (chronic inflammatory demyelinating polyneuropathy) trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error